[ad_1]
The Oxford University-AstraZeneca vaccine will not be exported for the first few months, according to the Indian manufacturer Serum Institute.
This was said by the head of the Serum Institute in an interview with an international media on Sunday. ABC and AP News.
Adar Punawala, CEO of the company, told AP that India would not allow the export of vaccines for a few months. The decision has been made so that the population of the country can receive the vaccine correctly.
According to the Serum Institute, countries that are interested in receiving their vaccines want to focus on producing the quantity of vaccines that India urgently needs two months before exporting.
By the way, so far more than a million people have been infected with corona in India, which is the second highest in the world. And he died about a lakh and a half.
India wants to vaccinate 300 million people at the start of the corona vaccine distribution scheme. In which priority will be given to front-line combatants, including health workers and the police. The Indian company will provide the vaccine to the government for 200 rupees.
It is worth mentioning that Bangladesh signed an agreement with the Serum Institute and Beximco Pharmaceuticals on November 5 to obtain 30 million doses of Covidshield Ticker manufactured by Oxford. Serum planned to vaccinate 5 million doses every month for six months in the first phase.
Bangladesh will have to wait a few more months for this sudden decision by the Indian organization.
[ad_2]
